Siemens Launches New Mid-volume Coagulation Analyzer and Celebrates Expanded Portfolio
August 03 2016 - 10:00AM
Business Wire
68th AACC Annual Scientific Meeting &
Clinical Lab Expo, Booth 2101
- Enables hemostasis laboratories to
standardize testing results across multipleSysmex CS and CA
hemostasis systems
- Enhances efficiency via a wide optical
spectrum, which allows clotting, chromogenic, immunologic and
aggregation1 testing capabilities on a single platform
Today, Siemens Healthineers Laboratory Diagnostics business
launched the Sysmex CS-2500 System—a mid-volume, fully-automated
coagulation analyzer with smartly-designed PSI technology—in major
markets including the U.S. Together with Lab Alliance of Central
New York, the first U.S. customer to install the high-volume Sysmex
CS-5100 System, the company celebrated the availability of its new
Sysmex CS Hemostasis System portfolio in the U.S.
The launch of the new Sysmex CS-2500 System will enable
mid-volume laboratories to leverage globally-proven PSI technology,
while providing regional reference laboratories and integrated
delivery networks (IDNs) with the ability to standardize testing
results across multiple Sysmex CS and CA hemostasis systems.
“Labs today are challenged to increase their output without
sacrificing the accuracy or reliability of their results. The
Sysmex CS Systems are the answer to this demand,” said Franz Walt,
President, Laboratory Diagnostics, Siemens Healthineers. “The
increased operational efficiency and uninterrupted workflow
delivered by the Sysmex CS-5100 and CS-2500 Systems provide our
customers with the confidence, consistency and increased capacity
they need to deliver timely and accurate hemostasis test
results.”
In most markets, the Sysmex CS-2500 System features simultaneous
multiwavelength scanning and proven PSI technologies including
primary-tube sample-volume checks, clog detection, assay-based
preanalytical sample-quality checks for hemolysis, icterus and
lipemia (HIL) interference;1 automated mixing studies;1 automated
platelet aggregation;1 and clot waveform analysis (CWA)2 —enabling
labs to raise the quality of test results, achieve cost-effective
method consolidation, simplify operations, and increase diagnostic
confidence.
The new system enhances efficiency via a wide optical spectrum,
which allows clotting, chromogenic, immunologic and aggregation1
testing capabilities on a single platform. With an onboard capacity
of up to 3,000 tests3 and up to 40 reagents, the Sysmex CS-2500
System delivers extended walkaway time to streamline workflow.
Anne Chamberlain, Hematology Manager at Laboratory Alliance of
Central New York, remarked, “The Sysmex CS Systems and the services
offered by Siemens Healthineers are the perfect fit for our
laboratory and laboratory networks similar to ours. The intuitive
system software, readily accessible patient analysis data and
result traceability simplifies our operations. This enables our lab
to deliver quality test results, which positively impacts patient
care for our clients.”
To help labs ensure consistency and improve productivity, the
systems use the same reagents, controls and calibrators as other
coagulation analyzers offered by Siemens Healthineers.
For more information about the Sysmex CS-2500 System, please
visit:
http://www.healthcare.siemens.com/hemostasis/systems/sysmex-cs-2500-system
1. The features (mentioned herein) are not commercially
available in all countries. Due to regulatory reasons their future
availability cannot be guaranteed. Please contact your local
Siemens organization for further details. 2. For Research Use Only.
Not for use in diagnostic procedures. 3. Based on internal
validation data from Sysmex Corporation.
Follow us on Twitter at
www.twitter.com/siemenshealth.
The products/features mentioned here are not commercially
available in all countries. Due to regulatory reasons their future
availability cannot be guaranteed. Further details are available
from the local Siemens organizations.
Siemens AG (Berlin and Munich) is a global technology
powerhouse that has stood for engineering excellence, innovation,
quality, reliability and internationality for more than
165 years. The company is active in more than
200 countries, focusing on the areas of electrification,
automation and digitalization. One of the world’s largest producers
of energy-efficient, resource-saving technologies, Siemens is
No. 1 in offshore wind turbine construction, a leading
supplier of gas and steam turbines for power generation, a major
provider of power transmission solutions and a pioneer in
infrastructure solutions as well as automation, drive and software
solutions for industry. The company is also a leading provider of
medical imaging equipment – such as computed tomography and
magnetic resonance imaging systems – and a leader in laboratory
diagnostics as well as clinical IT. In fiscal 2015, which ended on
September 30, 2015, Siemens generated revenue of
€75.6 billion and net income of €7.4 billion. At the end
of September 2015, the company had around 348,000 employees
worldwide. Further information is available on the Internet at
www.siemens.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160803005023/en/
Siemens HealthineersKimberly Nissen, +1
610-448-6355kimberly.nissen@siemens.com
Companhia Siderurgica Na... (NYSE:SID)
Historical Stock Chart
From Mar 2024 to Apr 2024
Companhia Siderurgica Na... (NYSE:SID)
Historical Stock Chart
From Apr 2023 to Apr 2024